Federal Register Notice: FDA’s Blood Products Advisory Committee will meet 7/31, from 8 a.m. to 5 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. On the morning of 7/31, the committee will meet in open session to discuss Baxter Healthcare’s BLA for HyQvia, Immune Globulin Infusion 10 % (human) combined with Recombinant Human Hyaluronidase for treating patients with primary immune deficiency disorders. In the afternoon, the committee will meet in open session to discuss reentry of blood donors deferred on the basis of Chagas disease test results. To view this notice, click here.